Nxera Pharma Co (Nxera Pharma Co) Price-to-Tangible-Book

: (As of Today)

View and export this data going back to . Start your Free Trial

As of today (2024-04-24), Nxera Pharma Co's share price is $9.72. Nxera Pharma Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.79. Hence, Nxera Pharma Co's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Nxera Pharma Co's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Nxera Pharma Co's highest Price to Tangible Book Ratio was 9.59. The lowest was 4.43. And the median was 5.32.

SOLTF's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.69
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Nxera Pharma Co's share price is $9.72. Nxera Pharma Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was $5.19. Hence, Nxera Pharma Co's P/B Ratio of today is 1.87.

Nxera Pharma Co Price-to-Tangible-Book Historical Data

The historical data trend for Nxera Pharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

9.56

5.00

4.76

3.69

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.69	5.48	3.35	-	-

Competitive Comparison

For the Biotechnology subindustry, Nxera Pharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co Price-to-Tangible-Book Distribution

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Price-to-Tangible-Book falls into.

Nxera Pharma Co Price-to-Tangible-Book Calculation

Nxera Pharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	9.72	/	-0.785
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Nxera Pharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.